These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30889607)

  • 1. Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults.
    Costache RC; Novac B; Bardan TR; Agapie DN; Edu A
    Urol Int; 2019; 102(4):468-475. PubMed ID: 30889607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.
    Esposito E; Campolo M; Casili G; Lanza M; Franco D; Filippone A; Peritore AF; Cuzzocrea S
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study.
    Cai T; Tamanini I; Cocci A; Di Maida F; Caciagli P; Migno S; Mereu L; Tateo S; Malossini G; Palmieri A; Verze P; Mirone V; Bjerklund Johansen TE
    Future Microbiol; 2019 Aug; 14():1013-1021. PubMed ID: 31469009
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children.
    Santos J; Musta V; Luca CM; Belei OA; Cambrea SC
    Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):325-331. PubMed ID: 33028102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study.
    Esposito E; Campolo M; Casili G; Lanza M; Franco D; Fazio E; Filippone A; Paterniti I; Cuzzocrea S
    Microb Physiol; 2020; 30(1-6):50-60. PubMed ID: 33070135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.
    Vogel T; Verreault R; Gourdeau M; Morin M; Grenier-Gosselin L; Rochette L
    CMAJ; 2004 Feb; 170(4):469-73. PubMed ID: 14970093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
    Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
    Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
    Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
    Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
    Klimberg I; Shockey G; Ellison H; Fuller-Jonap F; Colgan R; Song J; Keating K; Cyrus P
    Curr Med Res Opin; 2005 Aug; 21(8):1241-50. PubMed ID: 16083534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies.
    Fraile B; Alcover J; Royuela M; Rodríguez D; Chaves C; Palacios R; Piqué N
    Future Microbiol; 2017 Jun; 12():721-731. PubMed ID: 28345957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
    Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
    J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial.
    Bleidorn J; Gágyor I; Kochen MM; Wegscheider K; Hummers-Pradier E
    BMC Med; 2010 May; 8():30. PubMed ID: 20504298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
    McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
    Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of xyloglucan associations with gelatin or gelose on Escherichia coli-derived lipopolysaccharide-induced enteritis in rats.
    Theodorou V; Beaufrand C; Eutamene H
    Drugs Context; 2023; 12():. PubMed ID: 37908642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.